Aclarion, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ACON Nasdaq 3840 www.aclarion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aclarion, Inc.

Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 - Jan 13th, 2026 4:00 am
Aclarion Provides 2025 Update and 2026 Corporate Outlook - Jan 8th, 2026 4:00 am
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data - Jan 6th, 2026 4:00 am
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) - Dec 4th, 2025 6:00 am
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - Dec 2nd, 2025 6:00 am
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion - Nov 5th, 2025 4:00 am
Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH - Oct 22nd, 2025 4:00 am
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst - Oct 14th, 2025 4:09 am
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference - Oct 13th, 2025 4:00 am
Aclarion to Present at the LD Micro Main Event XIX - Oct 9th, 2025 4:00 am
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH - Oct 7th, 2025 4:00 am
Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers - Oct 1st, 2025 5:17 am
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial - Sep 25th, 2025 4:00 am
Aclarion Appoints Greg Gould as Chief Financial Officer - Sep 3rd, 2025 4:00 am
Aclarion Second Quarter 2025 Earnings: Misses Expectations - Aug 16th, 2025 7:34 am
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts - Aug 5th, 2025 4:00 am
Auddia Announces Non-binding Letter of Intent for Business Combination and Restructuring - Aug 5th, 2025 4:00 am
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders - Jul 7th, 2025 2:01 pm
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial - Jun 25th, 2025 4:00 am
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum - Jun 24th, 2025 5:00 am